| MODULE NAME: | Buprenorphine-mono and methadone prescriber training |
|---|---|
| MODULE CODE: | L3.2 - 3 |
| COURSE NAME: | QUEENSLAND OPIOID TREATMENT PROGRAM |
| LEARNING LEVEL: | Level 3 – AOD Treatment Specific Practice |
| TARGET AUDIENCE: | Prospective QOTP prescribers (medical and nurse practitioners only) |
| MODULE TYPE: | Elective |
| MODULE AIM: | This module aims to equip the learner with the knowledge required to safely and effectively prescribe buprenorphine-mono (Subutex®) and methadone for the treatment of opioid dependence. |
| LEARNING OUTCOMES: | By the end of this module, learners will be able to:
NB: This is the third module in the QOTP prescriber course. Successful completion of all 3 modules and completion of a clinical placement shadowing an experienced Level 1 prescriber is required to apply for authorisation as a Level 1 Full QOTP prescriber (authorised to prescribe all opioid dependence treatment medications available in Queensland). Completion of this module is not required if you are only seeking to apply for authorisation as a Level 2 - Specified QOTP prescriber. Do not commence this module if you have not already completed the first two QOTP modules as it assumes prior knowledge and theories contained within these previous courses. |
| LENGTH: | 30 minutes |
| CPD: | This module is accredited for:
Please refer to your Statement of Completion for full details. NB: Insight uploads CPD hours quarterly to ACRRM and RACGP. |
| REFERENCES: | Click here to download the reference list for this module. |
| LAST UPDATED: | August 2023 |